Concepedia

Publication | Open Access

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

DOIFull Paper Access

59

Citations

23

References

2023

Year

Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V. Long, Paolo A. Ascierto, James Larkin, Mario Sznol, Fábio Franke, Tudor–Eliade Ciuleanu, Caio Guilherme Pereira,
Journal of Clinical Oncology

Abstract

The PIVOT IO 001 study did not meet its primary end points of ORR, PFS, and OS. Increased toxicity was observed with BEMPEG plus NIVO versus NIVO.

References

YearCitations

Page 1